IP Library Granted Patent US 11,564,583
Granted Patent B2
US 11,564,583 · App. 17/099,675 · Granted Jan 31, 2023

Method for evaluating blush in myocardial tissue

Inventors: Peter Dvorsky (Toronto, CA); David Mark Henri Goyette (Mississauga, CA); T. Bruce Ferguson, Jr. (Raleigh, NC); Cheng Chen (Greenville, NC)
Assignee: Stryker European Operations Limited
A61B5/0275A61B5/0059A61B5/0261A61B5/489A61B5/7225A61B6/503A61M5/007G06T7/0012G06T7/12G06T7/248G06T7/90A61B6/504A61B6/507A61B2576/02G06T2207/10064G06T2207/30104
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,564,583
App. No.
17/099,675
Granted
Jan 31, 2023
Kind
B2
Abstract

Vessel perfusion and myocardial blush are determined by analyzing fluorescence signals obtained in a static region-of-interest (ROI) in a collection of fluorescence images of myocardial tissue. The blush value is determined from the total intensity of the intensity values of image elements located within the smallest contiguous range of image intensity values containing a predefined fraction of a total measured image intensity of all image elements within the ROI. Vessel (arterial) peak intensity is determined from image elements located within the ROI that have the smallest contiguous range of highest measured image intensity values and contain a predefined fraction of a total measured image intensity of all image elements within the ROI. Cardiac function can be established by comparing the time differential between the time of peak intensity in a blood vessel and that in a region of neighboring myocardial tissue both pre and post procedure.

Claims (17)

1. A system configured for determining perfusion in tissue using fluorescence imaging, the system comprising: a computing system and non-transitory computer-readable media with instructions to cause the computing system to:

define a static region of interest (ROT) in an image of tissue;

measure fluorescence intensity values of image elements (pixels) located within the ROI; and

determine a blush value from an average of the intensity values of image elements located within a smallest contiguous range of image intensity values containing a first predefined fraction of a total measured image intensity of all image elements within the ROI.

2. The system of claim 1 , wherein the smallest range of contiguous image intensity values is determined from a histogram of a frequency of occurrence of the measured image intensity values.

3. The system of claim 1 , wherein the first predefined fraction is between 70% and 30%, preferably between 60% and 40%, and most preferably at about 50%.

4. The system of claim 1 , wherein blush values are determined over a predefined period of time.

5. The system of claim 4 , wherein the blush values are determined continuously over the predefined period of time.

6. The system of claim 4 , wherein the instructions cause the computing system to determine a blush rate from a slope of the blush values.

7. The system of claim 4 , wherein the instructions cause the computing system to determine a washout rate from a slope of the blush values.

8. The system of claim 1 , wherein the instructions cause the computing system to:

define a second static ROI in the image of the tissue, with the second ROI including an arterial blood vessel, and

determine a measure of peak intensity of the arterial blood vessel from a total intensity of intensity values of image elements located within a smallest contiguous range of high image intensity values containing a second predefined fraction of a total measured image intensity of brightest image elements within the second ROI.

9. The system of claim 8 , wherein the second predefined fraction is approximately 20%.

10. The system of claim 8 , wherein the instructions cause the computing system to determine an outcome of a procedure by comparing an elapsed time between a maximum blush value and maximum measure of perfusion before the procedure and an elapsed time between a maximum blush value and maximum measure of perfusion after the procedure.

11. The system of claim 1 , wherein the system comprises a camera for generating the image.

12. The system of claim 1 , wherein the system comprises a fluorescence excitation light source.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
Continuity (9)
Continuation 15947221 · Apr 6, 2018
Continuation 15476290 · Mar 31, 2017
Continuation 14598832 · Jan 16, 2015
Division 13850063 · Mar 25, 2013
Division 12841659 · Jul 22, 2010
Continuation In Part PCTCA2009000073 · Jan 23, 2009
Provisional Application 61243688 · Sep 18, 2009
Provisional Application 61023818 · Jan 25, 2008
Related Publication 20210169354A1 · Jun 10, 2021